| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |